ADH1B and esophageal squamous cell carcinoma: Furthermore, the previous meta‐analysis did not use Venice criteria, false‐positive reporting probability (FPRP), and Bayesian false discovery probability (BFDP) to assess the epidemiological evidence of the ALDH2 and ADH1B polymorphisms and the ESCC risk.